Industry Growth Insights published a new data on “Microneedle-based Drug Delivery System Market”. The research report is titled “Microneedle-based Drug Delivery System Market research by Types (Hollow Microneedle Technology, Solid Microneedle Technology, Dissolving Microneedles Technology), By Applications (Drug Delivery, Vaccine Delivery, Other), By Players/Companies 3M, Zosano Pharma, Becton-Dickinson（BD）Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Microneedle-based Drug Delivery System Market Research Report
By Type
Hollow Microneedle Technology, Solid Microneedle Technology, Dissolving Microneedles Technology
By Application
Drug Delivery, Vaccine Delivery, Other
By Companies
3M, Zosano Pharma, Becton-Dickinson（BD）Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Microneedle-based Drug Delivery System Market Report Segments:
The global Microneedle-based Drug Delivery System market is segmented on the basis of:
Types
Hollow Microneedle Technology, Solid Microneedle Technology, Dissolving Microneedles Technology
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Delivery, Vaccine Delivery, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M
- Zosano Pharma
- Becton-Dickinson（BD）Technologies
- Nanopass Technologies
- Corium
- Valeritas
- Nitto
- Microdermics
- TheraJect
- Vaxxas
- Lohmann Therapie-Systeme AG
Highlights of The Microneedle-based Drug Delivery System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hollow Microneedle Technology
- Solid Microneedle Technology
- Dissolving Microneedles Technology
- By Application:
- Drug Delivery
- Vaccine Delivery
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microneedle-based Drug Delivery System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A microneedle-based drug delivery system is a technology that uses tiny needles to inject drugs directly into the body. This approach is often faster and more accurate than traditional methods, such as injections through a vein.
Some of the major players in the microneedle-based drug delivery system market are 3M, Zosano Pharma, Becton-Dickinson（BD）Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Microneedle-based Drug Delivery System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Microneedle-based Drug Delivery System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Microneedle-based Drug Delivery System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Microneedle-based Drug Delivery System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Microneedle-based Drug Delivery System Market Size & Forecast, 2018-2028
4.5.1 Microneedle-based Drug Delivery System Market Size and Y-o-Y Growth
4.5.2 Microneedle-based Drug Delivery System Market Absolute $ Opportunity
Chapter 5 Global Microneedle-based Drug Delivery System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Microneedle-based Drug Delivery System Market Size Forecast by Type
5.2.1 Hollow Microneedle Technology
5.2.2 Solid Microneedle Technology
5.2.3 Dissolving Microneedles Technology
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Microneedle-based Drug Delivery System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Microneedle-based Drug Delivery System Market Size Forecast by Applications
6.2.1 Drug Delivery
6.2.2 Vaccine Delivery
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Microneedle-based Drug Delivery System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Microneedle-based Drug Delivery System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Microneedle-based Drug Delivery System Analysis and Forecast
9.1 Introduction
9.2 North America Microneedle-based Drug Delivery System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Microneedle-based Drug Delivery System Market Size Forecast by Type
9.6.1 Hollow Microneedle Technology
9.6.2 Solid Microneedle Technology
9.6.3 Dissolving Microneedles Technology
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Microneedle-based Drug Delivery System Market Size Forecast by Applications
9.10.1 Drug Delivery
9.10.2 Vaccine Delivery
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Microneedle-based Drug Delivery System Analysis and Forecast
10.1 Introduction
10.2 Europe Microneedle-based Drug Delivery System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Microneedle-based Drug Delivery System Market Size Forecast by Type
10.6.1 Hollow Microneedle Technology
10.6.2 Solid Microneedle Technology
10.6.3 Dissolving Microneedles Technology
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Microneedle-based Drug Delivery System Market Size Forecast by Applications
10.10.1 Drug Delivery
10.10.2 Vaccine Delivery
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Microneedle-based Drug Delivery System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Microneedle-based Drug Delivery System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Microneedle-based Drug Delivery System Market Size Forecast by Type
11.6.1 Hollow Microneedle Technology
11.6.2 Solid Microneedle Technology
11.6.3 Dissolving Microneedles Technology
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Microneedle-based Drug Delivery System Market Size Forecast by Applications
11.10.1 Drug Delivery
11.10.2 Vaccine Delivery
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Microneedle-based Drug Delivery System Analysis and Forecast
12.1 Introduction
12.2 Latin America Microneedle-based Drug Delivery System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Microneedle-based Drug Delivery System Market Size Forecast by Type
12.6.1 Hollow Microneedle Technology
12.6.2 Solid Microneedle Technology
12.6.3 Dissolving Microneedles Technology
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Microneedle-based Drug Delivery System Market Size Forecast by Applications
12.10.1 Drug Delivery
12.10.2 Vaccine Delivery
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Microneedle-based Drug Delivery System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Microneedle-based Drug Delivery System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Microneedle-based Drug Delivery System Market Size Forecast by Type
13.6.1 Hollow Microneedle Technology
13.6.2 Solid Microneedle Technology
13.6.3 Dissolving Microneedles Technology
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Microneedle-based Drug Delivery System Market Size Forecast by Applications
13.10.1 Drug Delivery
13.10.2 Vaccine Delivery
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Microneedle-based Drug Delivery System Market: Competitive Dashboard
14.2 Global Microneedle-based Drug Delivery System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 3M
14.3.2 Zosano Pharma
14.3.3 Becton-Dickinson（BD）Technologies
14.3.4 Nanopass Technologies
14.3.5 Corium
14.3.6 Valeritas
14.3.7 Nitto
14.3.8 Microdermics
14.3.9 TheraJect
14.3.10 Vaxxas
14.3.11 Lohmann Therapie-Systeme AG
